| Característica |
Objectiu de la convocatòria
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. Gilead's portfolio of products and pipeline of investigational drugs includes treatments for HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular conditions.
|
Característiques principals
The program is designed to support basic and clinical research in the field of liver disease. Areas of research may include, but are not limited to:
Chronic viral hepatitis
End-stage liver disease and its complications
Non-viral chronic liver diseases
Basic, clinical, and translational research related to liver disease
|
Lloc de presentació
El personal de l'IMIM i PSMAR que necessiteu més informació adreceu-vos a:
Servei de Recerca. C/ Doctor Aiguader, 88. 08003-Barcelona. Tel.: 93.316.05.76.
Marta López: mlopez4@imim.es Ext.: 1576
Carol Barnwell: cbarnwell@imim.es Ext.1670
|
Convocatòria (URL)
http://researchscholarsld.gilead.com/overview
|
Requisits
Applicants must meet the following requirements:
Hold an MD, DO, PhD, or equivalent degree at time of award
Anticipate receiving a faculty appointment or an assistant professorship within 3 years, in association with a research institution in one of the eligible countries/regions at the time of application (see below for list of countries)
Have a strong career interest in liver disease
Have a research mentor with extensive experience in the field of liver disease
Be able to devote at least 50% of their professional time to research (versus administrative, patient care, or teaching responsibilities)
Be able to complete the proposed research within the 2-year award period, providing evidence (manuscript, presentation, or abstracts) for future research projects.
Applicants must reside in one of the eligible countries/regions: Australia, Europe, Middle East, New Zealand
An applicant must be a citizen or permanent resident of the country/region in which they propose to conduct the research, or otherwise hold a temporary study or nonimmigrant visa which allows legal residency in the country/region in which the research will be performed. Such visa must be valid for the two-year award period (1 June 2017 - 31 May 2019).
Awards granted under the program may not be duplicative of funding from institutional or hospital, other governmental, non-governmental, or industry sources. Applicants seeking an award for research projects that are currently receiving or may receive partial funding from other sources are required to submit appropriate evidence, including budget information related to the other sources, to demonstrate that there is no direct overlap or duplication in funding.
|
Dotació
Up to USD130,000, to be paid in annual installments of up to USD65,000 per year for 2 years.
|
Durada
Two years.
|
Documentació
Applicants must complete the online Application Form at http://researchscholarsld.gilead.com/application<(all fields must be completed or applicant will not be able to submit) and include the following Supplementary Materials as specified:
Research Abstract
Research Proposal
Applicant's biosketch, inclusive of publications, if applicable, using the template provided on the program's website
Mentor's biosketch, if applicable, using the template provided on the program's website
Letter of support from mentor which includes: mentor's track record of productivity, funding, and success with prior trainees; detailed description of the mentoring plan, including resources allocated to the proposed research project, provision of protected time, and available laboratory facilities
Bibliography of relevant references
Detailed budget and completed budget summary
Certification of Faculty Appointment from mentor is required and must be submitted with the Application, using the template provided (Download Certification of Faculty Appointment Template)
Current or Pending Funding, using the template provided (Download Current or Pending Funding Template)
Letter of support from the department chair or division chief that documents the institution is willing and has the ability to commit the resources necessary for the applicant to complete the proposed research, including sufficient protected time
|